Fangping Xu

发表

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Li-xu Yan, Yan-Hui Liu, J. Xiang, 2015, International journal of oncology.

External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China

Y. Weng, R. Shui, Wentao Yang, 2019, BMC Cancer.

Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases

Kun Wang, Yan-Hui Liu, Xin-lan Luo, 2019, Breast Cancer Research and Treatment.

Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines

Kun Wang, Yan-Hui Liu, Xin-lan Luo, 2017, Breast Cancer Research and Treatment.

Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancer.

F. Zhang, Yan-Hui Liu, Xin-lan Luo, 2009, American journal of clinical pathology.

Colon perforation due to cytomegalovirus infection in a patient with idiopathic hypereosinophilic syndrome: a case report

Yong Li, Fangping Xu, Junjiang Wang, 2020, BMC Gastroenterology.

SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas.

Y. Zeng, D. Xie, X. Guan, 2007, Cancer letters.

Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.

Enwei Xu, R. Shui, Wentao Yang, 2020, Clinical breast cancer.

The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas

Zhi Li, Fangping Xu, Jie Xu, 2022, Medicine.

A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature

Zhi Li, Fangping Xu, Zhihua Liu, 2019, Diagnostic Pathology.

[Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma].

Li-xu Yan, Fangping Xu, Jie Xu, 2015, Zhonghua bing li xue za zhi = Chinese journal of pathology.

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness

Li-xu Yan, Yan-Hui Liu, Xin-lan Luo, 2016, Cancer medicine.

Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma.

Yi-long Wu, Jin-Ji Yang, Chao Zhang, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.

J. Sung, H. Kung, D. Xie, 2010, Cancer letters.

Timing and origins of local and distant metastases in lung cancer.

Yi-long Wu, W. Zhong, Yang Xu, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Intravascular NK/T-cell lymphoma: a series of four cases.

Su Yao, Yan-Hui Liu, Xin-lan Luo, 2017, International journal of clinical and experimental pathology.

Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers.

Jin-Ji Yang, Xue-Ning Yang, W. Zhong, 2015, Lung cancer.

Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

M. Lerman, S. Law, M. Lung, 2007, Cancer letters.

Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.

Fangping Xu, J. Bi, Meng Zhang, 2006, American journal of clinical pathology.

Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour

Su Yao, Xin-lan Luo, Fangping Xu, 2017, Histopathology.

[Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].

Yan-Hui Liu, Xin-lan Luo, Fangping Xu, 2011, Zhonghua bing li xue za zhi = Chinese journal of pathology.

Efficacy of intraoperative GeneSearch Breast Lymph Node (BLN) Assay for breast cancer metastasis detection in sentinel lymph node in Chinese patients

N. Liao, Yan-Hui Liu, Xin-lan Luo, 2010, Cancer science.

Primary breast telangiectatic osteosarcoma: a rare entity and a potential diagnostic pitfall.

Zhi Li, Fangping Xu, Zhihua Liu, 2020, Pathology.

A decision tree-based prediction model for fluorescence in situ hybridization HER2 gene status in HER2 immunohistochemistry-2+ breast cancers: a 2538-case multicenter study on consecutive surgical specimens

Jinfen Wang, Yueping Liu, Jiayuan Li, 2018, Journal of Cancer.

Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.

D. Xie, Yan-Hui Liu, Xin-lan Luo, 2008, Human pathology.

Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation

Su Yao, Xin-lan Luo, Fangping Xu, 2017, Journal of experimental & clinical cancer research : CR.

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

J. Yun, Li-xu Yan, Xin-lan Luo, 2013, Diagnostic Pathology.

Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy

Yi-long Wu, N. Liao, Kun Wang, 2013, Tumor Biology.

HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.

Yi-long Wu, N. Liao, Yan-Hui Liu, 2011, Pathology, research and practice.

High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2021, Thoracic Cancer.

Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy

Kun Wang, Fangping Xu, T. Zhu, 2017, Oncotarget.

External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China

Y. Weng, R. Shui, Wentao Yang, 2019, BMC Cancer.

A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer

N. Liao, X. Li, C. Liu, 2016, Breast Cancer Research and Treatment.

Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation

Su Yao, Xin-lan Luo, Fangping Xu, 2017, Journal of Experimental & Clinical Cancer Research.

Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers.

Jin-Ji Yang, Xue-Ning Yang, W. Zhong, 2015, Lung Cancer.